EUVIMEDEUVIMED entdecken
Crossref

Abstract 1405: Association of Admission Hyperglycemia With Discharge Outcomes and Vasospasm After Aneurysmal Subarachnoid Hemorrhage

O. Alwakaa, T. Fodor, J. Metu, R. Regenhardt, B. Benitez, C. Fehnel, J. Yoon, M. H. Selim, P. Taussky, J. H. Granstein, C. S. Ogilvy, A. S. Das

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_1405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von O. Alwakaa und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Stress hyperglycemia is common after acute neurologic injury and may reflect hypothalamic-pituitary-adrenal activation, sympathetic discharge, and systemic inflammatory stress. Although admission hyperglycemia has been associated with unfavorable outcomes after ischemic and hemorrhagic stroke, its prognostic relevance after aneurysmal subarachnoid hemorrhage (aSAH) and its relationship to cerebral vasospasm remain incompletely defined. We evaluated whether admission glucose was independently associated with poor functional outcome at discharge and whether it predicted subsequent transcranial Doppler-defined vasospasm.

Methods

We performed a retrospective, single-center cohort study of patients with confirmed aSAH admitted between 2003 and 2024. Given variability in previously used definitions of hyperglycemia and to evaluate potentially clinically meaningful thresholds, admission glucose was analyzed continuously per 10-mg/dL increase and categorically using cutoffs of >140 mg/dL and >180 mg/dL. Separate multivariable logistic regression models evaluated poor discharge functional outcome (modified Rankin Scale [mRS] score ≥ 3) and vasospasm. Models included age, admission glucose, baseline mRS, Hunt-Hess score, and additional clinically relevant baseline and admission variables associated with the respective outcome at p 0.10 in univariable analyses.

Results

The cohort included 368 patients (mean age 56.4±14.2 years, 67% female, median admission glucose 137 mg/dL [interquartile range 117-170]), of whom 199 (54.1%) developed vasospasm and 172 (46.7%) had a poor discharge outcome. In the multivariable model, which also adjusted for diabetes, hypertension, admission systolic blood pressure, anemia during hospitalization, and EVD presence (all p < 0.1 in univariable analyses), each 10-mg/dL increase in admission glucose was associated with 9% higher odds of poor outcome (adjusted odds ratio [aOR] 1.09, 95% confidence interval [CI] 1.02-1.17, p ≤ 0.001). Hyperglycemia was similarly associated with poor outcome at thresholds of >140 mg/dL (aOR 2.60, 95% CI 1.51-4.46, p =0.001) and >180 mg/dL (aOR 2.46, 95% CI 1.17-5.17, p ≤ 0.001). In contrast, after additionally adjusting for smoking history, admission systolic blood pressure, admission hemoglobin, EVD presence, aneurysmal re-rupture, and hyponatremia (all p < 0.1), admission glucose was not associated with the development of vasospasm when analyzed continuously (aOR per 10-mg/dL increase 0.99, 95% CI 0.94-1.04, p = 0.101) or at thresholds of >140 mg/dL (aOR 0.97, 95% CI 0.60-1.57, p = 0.787) or >180 mg/dL (aOR 1.19, 95% CI 0.64-2.24, p = 0.114).

Conclusion

Admission hyperglycemia was independently associated with poor discharge functional outcome after aSAH but was not associated with cerebral vasospasm. The consistent associations across glucose specifications support admission glucose as an immediately available marker for early outcome risk stratification. However, admission glucose was not associated with cerebral vasospasm, suggesting its prognostic value may reflect global neurologic injury severity rather than a vasospasm-mediated pathway.

Zitieren

APA

Alwakaa, O., Fodor, T., Metu, J., Regenhardt, R., Benitez, B., Fehnel, C., Yoon, J., Selim, M. H., Taussky, P., Granstein, J. H., Ogilvy, C. S., & Das, A. S. (2026). Abstract 1405: Association of Admission Hyperglycemia With Discharge Outcomes and Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1405

Vancouver

Alwakaa O, Fodor T, Metu J, Regenhardt R, Benitez B, Fehnel C, et al. Abstract 1405: Association of Admission Hyperglycemia With Discharge Outcomes and Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1405

BibTeX
@article{Alwakaa2026,
  author = {Alwakaa, O. and Fodor, T. and Metu, J. and Regenhardt, R. and Benitez, B. and Fehnel, C. and Yoon, J. and Selim, M. H. and Taussky, P. and Granstein, J. H. and Ogilvy, C. S. and Das, A. S.},
  title = {Abstract 1405: Association of Admission Hyperglycemia With Discharge Outcomes and Vasospasm After Aneurysmal Subarachnoid Hemorrhage},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_1405}
}
Kostenlos starten →